Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v10-EN | Version v7-FR | |
---|---|---|
Language | English | French |
Date Updated | 2022-10-01 | 2022-09-30 |
Drug Identification Number | 02359499 | 02359499 |
Brand name | MOVIPREP | MOVIPREP |
Common or Proper name | Macrogol 3350, Sodium sulphate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid, Sodium ascorbate | Macrogol 3350, Sodium sulphate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid, Sodium ascorbate |
Company Name | ARALEZ PHARMACEUTICALS CANADA INC | ARALEZ PHARMACEUTICALS CANADA INC |
Ingredients | ASCORBIC ACID SODIUM ASCORBATE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM SULFATE ANHYDROUS POLYETHYLENE GLYCOL 3350 | ASCORBIC ACID SODIUM ASCORBATE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM SULFATE ANHYDROUS POLYETHYLENE GLYCOL 3350 |
Strength(s) | 4.7G 5.9G 1.015G 2.691G 7.5G 100G | 4.7G 5.9G 1.015G 2.691G 7.5G 100G |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | cartons containing 2 sachets A and 2 sachets B | cartons containing 2 sachets A and 2 sachets B |
ATC code | A06AD | A06AD |
ATC description | DRUGS FOR CONSTIPATION | DRUGS FOR CONSTIPATION |
Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
Anticipated start date | ||
Actual start date | 2022-08-10 | 2022-08-10 |
Estimated end date | ||
Actual end date | 2022-09-30 | 2022-09-30 |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |